Chugai Pharmaceutical Co., Ltd. · Tokyo Japan
| 1-1 Nihonbashi-Muromachi 2-Chome, Chuo-Ku | Phone: +81-3-3281-6611 |
| Tokyo | Fax: +81-3-3281-2828 |
| 103-8324 | |
| Japan | 
Map This Company |
- Company Profiles
- Competitive Landscapes
- Industry Reports
Buy Reports
For a Hoover's Free Trial, Call
(866) 444-8642or
Chat NowChugai Pharmaceutical Co., Ltd. Rankings
Company Description
Chugai Pharmaceutical develops therapies for bone metabolism and blood disorders, cancer, infectious diseases, immune system disorders, and cardiovascular, kidney, and brain diseases. Products include Neutrogin, which treats white blood cell loss related to chemotherapy; Epogin, which treats red blood cell loss caused by chronic kidney failure; Sigmart, an antianginal agent; and Alfarol for osteoporosis. Chugai Pharmaceuticals has foreign operations in Asia, Europe, and North America through subsidiaries and branch locations. Swiss drugs group Roche owns about 60% of Chugai Pharmaceutical.
Chugai Pharmaceutical Co., Ltd. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Top Chugai Pharmaceutical Co., Ltd. Competitors
